Industry Outlook 2025: A Busy Time Ahead In an interview with Pharmaceutical Technology®, Tore Bergsteiner from MAIN5 details his predictions for how the mega trends will shape the bio/pharma industry in 2025 and beyond.
https://www.pharmtech.com/view..../industry-outlook-20

Grifols clinical trial shows positive results for post-polio patients https://pharmatimes.com/news/g....rifols-clinical-tria

Rxulti approved in the European Union for adolescent schizophrenia https://pharmatimes.com/news/r....xulti-approved-in-th

Sun Pharma Agrees to Acquire Checkpoint Therapeutics The transaction includes Unloxcyt (cosibelimab-ipdl), which was approved by FDA in December 2024 for treatment of adults with cutaneous squamous cell carcinoma (cSCC).
https://www.pharmtech.com/view..../sun-pharma-acquire-

Industry Outlook 2025: Fostering the Development of Biotech in Europe In an interview with Pharmaceutical Technology®, Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
https://www.pharmtech.com/view..../industry-outlook-20